DiaSorin Provides Overview of Alterations in Bone and Mineral Metabolism in Patients with Chronic Kidney Disease (CKD) in Informative Webinar

Share Article

Participants of this webinar, sponsored by DiaSorin on December 6, will learn more about the bone metabolic disorder in CKD patients and the KDIGO recommendations concerning the measurement of the serum concentration of PTH, vitamin D metabolites and FGF23.

Jean-Claude Souberbielle (JCS), Ex head of Laboratoire d'explorations fonctionnelles hôpital Necker-Enfants malades

Alterations in the bone and mineral metabolism is of great concern in patients with chronic kidney disease (CKD). As the glomerular filtration rate (GFR) decreases, phosphatemia tends to increase while the renal secretion of the active vitamin D metabolite decreases with, consequently, increases in both serum PTH and FGF23 levels. This the pathophysiological basis of the so-called CKD-bone and mineral disorders (MBD). Experts in Nephrology have published international guidelines, called the KDIGO/CKD-MBD, to help colleagues deal with these disorders.

The speaker for this webinar will be Mr. Jean-Claude Souberbielle (JCS), now retired (but still active) and who was the Ex head of the hormone laboratory in the Department of Physiology of the University Necker-Enfants Malades Hospital in Paris, France, and an invited Professor at the Liège University, Belgium. Its main research/clinical topics were the growth hormone/IGFI axis and all aspects of bone and mineral metabolism.

Souberbielle will explain the mechanism that regulates the calcium and phosphorus absorption in patients with altered hormone activities and the utility of a few fundamental markers to determine the CKD patient management.

LabRoots will host this webinar December 6, 2018, beginning at 6:00am PST, 9:00am EST, 3:00pm CET. To learn more about this event, the continuing education credits offered, or to register for free, click here.

About DiaSorin
Headquartered in Italy and listed in the FTSE Italia Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostic (IVD) field. For over 50 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets, which identify DiaSorin Group as the “Diagnostic Specialist”.

About LabRoots
LabRoots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. We have become a primary source for trending scientific news, webinars, virtual conferences and more. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Join for free and become part of the largest scientific learning community in the world.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Hilary Thompson
LabRoots, Inc.
+1 (707)407-8355
Email >
Visit website